Nardetto Lucia, Dario Claudio, Tonello Simone, Brunelli Marta Carla, Lisiero Manola, Carraro Maria Grazia, Saccavini Claudio, Scannapieco Gianluigi, Giometto Bruno
Department of Neurology, Clinica Neurologica II, via Facciolati 71, 35127, Padua, Italy.
Azienda Ospedaliera di Padova, Padua, Italy.
Neurol Sci. 2016 May;37(5):725-30. doi: 10.1007/s10072-016-2569-y. Epub 2016 Mar 31.
Over 10 years after European approval, thrombolysis is still limited by a restricted time window and non-optimal territorial coverage. Implementation of telestroke can give a growing number of patients access to treatment. We hereby present the first Italian telemedicine study applied to both the acute and the monitoring phase of stroke care. From January 2011 to December 2013, we tested a web-based, drip, and treat interaction model, connecting the cerebrovascular specialist of one hub center to the Emergency Department of a Spoke center. We then compared thrombolysis delivered using the telestroke model with thrombolysis provided at the Hub Stroke Unit at the time when the telemedicine program was activated. Telethrombolysis data were then compared with data from the two main international telestroke projects (TEMPiS and REACH), and other European telestroke studies performed at the time of writing. We collected a total of 131 thrombolysis procedures (25 telethrombolysis and 106 thrombolysis patients at the Stroke Unit). Statistical analysis with the t test yielded no statistically significant differences between the two populations in door-to-scan, door-to-needle (DTN), and onset-to-treatment times (OTT). Our OTT and DTN pathway times were longer than the TEMPiS and REACH studies but comparable with other European telemedicine trials, despite different models of interaction and number of centers. Our study in a northeastern province of Italy confirms the potential of applying telemedicine to a cerebrovascular pathology.
在欧洲批准使用超过10年后,溶栓治疗仍然受到时间窗受限和区域覆盖不理想的限制。远程卒中的实施可以让越来越多的患者获得治疗。在此,我们展示了第一项应用于卒中护理急性期和监测期的意大利远程医疗研究。从2011年1月至2013年12月,我们测试了一种基于网络的、“点滴治疗”交互模式,将一个中心枢纽的脑血管专家与一个辐条中心的急诊科连接起来。然后,我们将使用远程卒中模式进行的溶栓治疗与在远程医疗项目启动时枢纽卒中单元提供的溶栓治疗进行了比较。随后,将远程溶栓数据与两个主要的国际远程卒中项目(TEMPiS和REACH)以及撰写本文时进行的其他欧洲远程卒中研究的数据进行了比较。我们总共收集了131例溶栓治疗病例(25例远程溶栓和106例卒中单元溶栓患者)。采用t检验进行统计分析,结果显示两组人群在门到扫描、门到针(DTN)和发病到治疗时间(OTT)方面无统计学显著差异。尽管交互模式和中心数量不同,但我们的OTT和DTN路径时间比TEMPiS和REACH研究更长,但与其他欧洲远程医疗试验相当。我们在意大利东北部一个省份进行的研究证实了将远程医疗应用于脑血管疾病的潜力。